Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-15-015140)

Filing Details

Accession Number:
0001209191-15-015140
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-18 14:01:59
Reporting Period:
2015-02-13
Filing Date:
2015-02-18
Accepted Time:
2015-02-18 14:01:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1024004 F David Hale C/O Biocept, Inc.
5810 Nancy Ridge Drive #150
San Diego CA 92121		 Chairman Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-13 40,000 $1.25 94,570 No 4 P Indirect By LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By LLC
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2015-02-13 40,000 $0.00 40,000 $1.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2015-02-13 2020-02-13 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,204 Direct
Footnotes
  1. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.25 per unit.